These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1633509)

  • 1. The detection of minimal residual disease in acute lymphoblastic leukaemia.
    Potter MN
    Blood Rev; 1992 Jun; 6(2):68-82. PubMed ID: 1633509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye.
    Li AH; Forestier E; Rosenquist R; Roos G
    Exp Hematol; 2002 Oct; 30(10):1170-7. PubMed ID: 12384148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal selection in acute lymphoblastic leukaemia demonstrated by polymerase chain reaction analysis of immunoglobulin heavy chain and T-cell receptor delta chain rearrangements.
    Langlands K; Craig JI; Anthony RS; Parker AC
    Leukemia; 1993 Jul; 7(7):1066-70. PubMed ID: 8391615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Australian and New Zealand Children's Cancer Study Group.
    Brisco MJ; Condon J; Hughes E; Neoh SH; Nicholson I; Sykes PJ; Tauro G; Ekert H; Waters K; Toogood I
    Leukemia; 1993 Oct; 7(10):1514-20. PubMed ID: 8412313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia.
    Potter MN; Steward CG; Oakhill A
    Br J Haematol; 1993 Mar; 83(3):412-8. PubMed ID: 8485046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias.
    d'Auriol L; Macintyre E; Galibert F; Sigaux F
    Leukemia; 1989 Feb; 3(2):155-8. PubMed ID: 2536129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia].
    Lazić J; Dokmanović L; Krstovski N; Predojević J; Tosić N; Pavlović S; Janić D
    Srp Arh Celok Lek; 2009; 137(7-8):384-90. PubMed ID: 19764592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
    Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
    J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Zuna J; Hrusák O; Kalinová M; Muzíková K; Zörnerová T; Starý J; Trka J
    Vnitr Lek; 2000 Aug; 46(8):465-9. PubMed ID: 11048511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse.
    Lal A; Kwan E; al Mahr M; Zhou L; Ferrara D; Tobias V; O'Gorman Hughes D; Haber M; Norris MD; Marshall GM
    Mol Pathol; 1998 Oct; 51(5):277-81. PubMed ID: 10193523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease in acute lymphoblastic leukaemia--PCR analysis of immunoglobulin gene rearrangements.
    Cole-Sinclair M; Foroni L; Wright F; Mehta A; Prentice HG; Hoffbrand AV
    Leuk Lymphoma; 1993; 11 Suppl 2():49-58. PubMed ID: 8124233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of minimal residual disease in ALL.
    Deane M; Hoffbrand AV
    Cancer Treat Res; 1993; 64():135-70. PubMed ID: 8095791
    [No Abstract]   [Full Text] [Related]  

  • 15. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
    Guidal C; Vilmer E; Grandchamp B; Cavé H
    Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
    [No Abstract]   [Full Text] [Related]  

  • 16. Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia.
    Nyvold C; Madsen HO; Ryder LP; Seyfarth J; Engel CA; Svejgaard A; Wesenberg F; Schmiegelow K
    J Immunol Methods; 2000 Jan; 233(1-2):107-18. PubMed ID: 10648861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
    Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
    Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
    van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
    Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response.
    Foroni L; Coyle LA; Papaioannou M; Yaxley JC; Sinclair MF; Chim JS; Cannell P; Secker-Walker LM; Mehta AB; Prentice HG; Hoffbrand AV
    Leukemia; 1997 Oct; 11(10):1732-41. PubMed ID: 9324295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
    Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
    Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.